Key result
Head and neck microvascular free tissue transfer achieves ~95% success with protocolized perioperative care.
Microvascular free tissue transfer is a reliable technique for head and neck reconstruction with success rates of 90-99%. Currently, there is no consensus concerning antithrombotic agents, antibiotics, or monitoring techniques. Therefore, the aim of this study was to review current literature dealing with microvascular free-tissue transfer and factors influencing the outcome. In addition to excellent microsurgical techniques, coupling devices are a promising new technique, but are not useful in all arteries. Antibiotics should be given in three doses, as a more lengthy dosage time seems to have no advantage. The risk for elderly patients can be best assessed by the American Society of Anesthesiologists (ASA) score, but early mobilization, including intense chest physiotherapy, is important. Anticoagulation can be considered in cases of small vessels, significant size mismatch, vein graft, or vessels of poor quality. Monitoring should be done hourly during the first 24 hours and then every 4 hours for the next 2 postoperative days.
No takes yet. Share an insight, caveat, or question.
Kruse et al. (2010) conducted a review in Cancer of the head and neck requiring reconstruction. Microvascular free tissue transfer was evaluated on Free-flap survival and outcome. Microvascular free tissue transfer for head and neck reconstruction has a 90-99% success rate, which may be supported by short-term antibiotics, selective anticoagulation, and intensive monitoring.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: